It is important to document changes in the vital statistics of epilepsy in the general population so that the success or failure of prevention and treatment can be assessed and health provisions planned. A population of 6000 persons was studied 10 years apart to determine secular trends in the prevalence and prognosis of epilepsy. The lifetime prevalence of all patients with one or more afebrile seizures was 20 3/1000 (95% CI 16-9-24-3) in 1983 and 21-0/1000 (95% CI 17.6-25-1) in 1993. The prevalence of active epilepsy was 5 3/1000 (95% CI 3.6-7.5) in 1983 and 4-3 (95% CI 2.8-6.3) in 1993. To assess trends in incidence rates the annual first attendance rates were measured from 1964 to 1993. Annual first attendance rates in children (age < 20 years) have declined from 152 4/100 000 (90% CI 106-0-212-9) in the years 1974-83, to 60*9/100 000 (90% CI 33*0-103.3) in the years from 1984-93, suggesting that the incidence of epilepsy in children is falling. Also noteworthy was the first attendance rates for epilepsy in elderly people (61-80 years) in the years 1984-93, of 82-0 (90% CI 38-5-154-0), higher than in any other age group. This increase in the number of elderly patients with epilepsy is important, and has health planning implications, especially with the overall increase in the total elderly population. There was, however, no evidence that prognosis has significantly altered in the past 40 years. (U Neurol Neurosurg Psychiatry 1995;58:570-576) 
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(U Neurol Neurosurg Psychiatry 1995;58:570-576) Keywords: epilepsy; secular trends; prevalence; prognosis A number of factors may have influenced the epidemiology of epilepsy over the past century. Firstly, there have been major demographic alterations in the population structure. In the developed countries there has been a declining birth rate and a rising life expectancy with an increase in the number of elderly people. Epilepsy is more common in the early and later decades of life and, therefore, changes to the population structure should also change the age specific prevalence rates. Secondly, there may have been changes in proportion of different aetiologies that cause epilepsy. For instance, there has been a fall in perinatal mortality in the developed world,' with a general improvement in perinatal health, so epilepsy that arises as a consequence of perinatal infection and trauma might also be expected to decline. This has led to suggestions that the incidence of epilepsy has fallen in the past decades in both Europe, and the United States.2A Lastly, the treatment of epilepsy have improved over the past three decades. We have seen the introduction of new antiepileptic drugs, better use of existing ones, and advances in the early recognition and treatment of status epilepticus, and other complications of epilepsy, and there has been speculation that there has been an improvement in the prognosis of epilepsy in recent years.56
In this study to determine trends in the dynamics of epilepsy epidemiology a population of 6000 persons was examined 10 years apart. The same general practice population was the subject of a study in 1983.7
Subjects and methods All patients with epilepsy in a population of 6000 (defined, as in 1983, as all the patients on the list of one general practitioner, DMGG, and the subsequent alphabetical names in the remainder of the practice list to bring the population to exactly 6000) were ascertained. Patients were identified by the same method of case ascertainment as was employed in 1983: all the general practitioner notes in the specified population of 6000 were examined, looking for a mention of epileptic seizures in letters, tests, and prescriptions, or in the actual general practitioner's hand written notes. We also supplemented this by looking for patients on the practice computer patient management system registered as having epileptic seizures, and for patients with a current antiepileptic drug prescription. In this study we used a combination of medical record review, information from the 1983 study, and a questionnaire to obtain data on each patient. In 1993 over 96% of patients had been referred to a neurologist or other physician and the notes gave a clear account of the seizures in letters, hospital summaries, or the original notes written by the general practitioner. Most (over 75%) patients had had EEGs, and in recent years, CT or MRI (52% of new onset cases in the past 10 years having CT). Because of the absence of a patient interview the determination of the exact number of seizures may have been inaccurate in some patients. The exact numbers of seizures, or patient attitudes to their treatment, were not being examined in this study, and we think that the lack of an interview does not detract from the validity of the data.
POPULATION OF TONBRIDGE
The population of the town of Tonbridge is homogenous compared with the rest of the United Kingdom. There are higher proportions in the higher social classes and the bulk of the population was born in the United Kingdom. Over the past 50 years the population has undergone some alteration. After the second world war the proportion of men between 20-40 years of age was significantly less than women and the proportions under 10 years of age was 15-6%. This changed in the 1960s, with an increase in the young male population together with a rising birth rate (over 18% in the under 10 age group). This then gradually fell to a level of 13% in the past two decades. Against this there has been a marginal increase in the number of elderly people, with 8-7% over 71 in 1951, and 8-8% in 1992; the percentage over 81 has risen, especially in women. The population of the practice 6000 in 1983 and 1993 very closely mirrored the age and sex distribution of the town, and is therefore likely to be representative for the town of Tonbridge. The 6000 population of the study is an epidemiological window on the whole United Kingdom population with migration in and out. There is no evidence from the Office of Population Census and Surveys that there is a tendency for different types of people to move in or out of the town and we believe that the population is reasonably representative of the whole United Kingdom. It is unknown whether ethnicity or social class have any influence on the epidemiology of epilepsy in the United Kingdom. In the United States one study showed a higher prevalence of epilepsy in the black population,'3 and in Colombia there was a slightly higher rate in patients of a low social class. 14 THE 1983 AND 1993 PREVALENCE SURVEYS The lifetime prevalence of 20 3/1000 in 1983 and 21 0/1000 in 1993 is not significantly different. This is important from a health planning perspective, but as pointed out elsewhere,'5 similar prevalence results may mask more significant trends in incidence and mortality. The prevalence rates are higher than in other studies in the developed world that have also calculated lifetime prevalence rates with various methodologies,15-'9 although closer to well conducted door to door surveys, which have reported rates of up to 19.5/1000.1420 When single seizures and unprovoked seizures are excluded the rates are still 14 5/1000 and 14 6/1000 in both the 1983 and 1993 survey dates. This reflects the success with which longstanding inactive cases were identified with the general practitioner system. The rates for active epilepsy (4 3/1000 in 1993) were the same order of magnitude as in other studies. [21] [22] [23] [24] [25] Age and sex distribution The age and sex distribution in the two prevalence surveys were similar, both in terms of age of onset and age at time of survey. There is a small decrease in the prevalence of children under 20 years of age in the 1993 (102/1000), 95% CI 5-9-16-3) compared with the 1983 survey (14.9/1000, 95% CI 5% CI 8 3-24.6). Lifetime prevalence is reasonably proportional to cumulative incidence in children,"5 and this fall in the age specific lifetime prevalence rate may be due to a fall in the incidence of epilepsy in children; however the numbers were small and the confidence limits wide. This is discussed when first attendance rates are considered. The female to male preponderance, which was at odds with other prevalence studies, continued in 1993.1524 Lifetime prevalence is highest in the middle years of life (35-0/1000 for ages 31-40 years) whereas the prevalence of active epilepsy is highest in elderly people (6 1/1000 for ages over 60). Prevalence surveys that identified patients with active epilepsy have usually reported a peak in children under 20, 72425 whereas lifetime prevalence may be highest in children,'920 or other age groups (30-50 years,20 over 70 years '5) , and is closely related to the effectiveness of ascertaining cases of inactive epilepsy in each age group. The peak of active epilepsy in elderly people in our study is consistent with data from Rochester and Warsaw, where there was a higher rate in elderly people.'°15 There is evidence elsewhere that the number of elderly patients has risen over the past 10 There was a low prevalence of myoclonic seizures, which may serve as a marker for patients who have juvenile myoclonic epilepsy and the other primary generalised epilepsies. This may be partly due to the absence of a patient interview leading to failure to pick up such seizures; however, most young patients were seen by a specialist, and we believe our estimate to be reasonably accurate.
Aetiology
In agreement with other studies the aetiology is unknown in over 70% of patients.'5 This figure depends on the sophistication and degree to which investigations are applied,28 and would be expected to decrease with the introduction of CT and MRI. The prevalence population includes a high number of inactive cases who do not warrant any investigation, and it will take many years before the improved investigation of new onset, and the few intractable, cases feed through into the prevalence population. In the NGPSE, which identified patients at the population level in the United Kingdom between 1984 and 1987, the number of unknown aetiologies was considerably less (61%). 26 The idiopathic group includes patients with primary generalised epilepsies, but, as discussed, with such a low prevalence of myoclonic and absence seizures the percentage of patients likely to be included in this category is probably small. There is no apparent difference in the type of aetiologies in the 1983 and 1993 surveys, except that the number of traumatic seizures has fallen. This may be related to an overall significant decrease in fatal road accidents in the United Kingdom, probably due to the introduction of new motorcycle and car safety laws.'
FIRST ATTENDANCE RATES First attendance rates are a measure first used in epilepsy by Zielinski, who calculated the first attendance rates of patients attending a specialist neurological hospital.'0 These rates were considerably lower than incidence rates estimated from a population based survey, and Zielinski concluded that first attendance rates were a poor guide to incidence. Hospital attendance is a poor way of ascertaining epilepsy, but attendance rates that use general practitioner based populations are, as discussed, a much better method of ascertaining cases of epilepsy in a defined population. First attendance can therefore be used as an estimate of the incidence of epilepsy, but rates calculated retrospectively from a cross sectional population may not be proportional to the incidence. There are four main factors that may affect the relation between the two measures'015 30: (1) Patients with epilepsy may move out of the population being surveyed and will therefore be missed in any retrospective method. In our study population however, patients with epilepsy who moved away were then replaced in the surgery list by patients who moved into the area, and so the two variables will cancel each other out unless one predominates. For instance, patients may perceive that a practice offers advantages to patients with epilepsy (there is no evidence for this occurring in the Tonbridge practice). (2) Patients with epilepsy may die and will be missed in retrospective surveys (unless accurate death registers are kept). In a similar population in the United Kingdom, the NGPSE has recently reported on the mortality of patients with epilepsy.3' The rate was highest in the first few years, and after five years it was little different from the standard population. Thus in a newly diagnosed cohort of patients with epilepsy in a general practitioner population about 20% of patients with epilepsy died in the first five years, and thereafter about 1 % died per year." The deaths mostly occurred in elderly patients and less than 5% of deaths occurred in patients under 24 years, and all these occurred in the first two years. This means that first attendance rates for patients in the younger age groups are likely to be closer to the true incidence rates and not significantly affected by mortality. (3) Retrospective analysis is prone to miss patients as the data become more incomplete and past occurrences get missed. This is not likely to have a significant affect in our study where all the patient's lifetime history was well documented in the general practitioner's notes, and even single seizures are likely to have been recorded (assuming medical attention was sought). (4) Epilepsy is often difficult to diagnose and in the NGPSE, diagnosis of patients with new onset epilepsy was delayed for more than six months in 20% of cases.26 This is likely to affect the relation between first attendance rates and incidence in the five years before the survey dates. This may suggest that the first attendance rates for the period 1974 to 1983 will be lower when calculated from the 1983 rather than the 1993 survey populations. When this was performed there was no major difference between the two estimations.
Two interesting findings can be made from first attendance rates estimated in our study. Firstly, there has been a decrease in the first attendance rates in children (persons under 20 years) over the years from 1964 to 1993, with the biggest fall in the past decade. This provides evidence for a corresponding decrease in the number of incident cases.
There have only been a few studies that have looked at the influence of time trends on the incidence of epilepsy,2424 although the hazards of attempting to determine incidence rates calculated retrospectively from a cross sectional population were not considered in one study. 24 In Rochester, United States, from 1935 to 1984 there was no significant difference in overall incidence, but this masked strong underlying trends.' The incidence in children declined by 40% between the earliest and latest time interval, whereas the incidence in the elderly population almost doubled. In an Italian study, the rate varied from 30 5 to 36 6/100 000 and no significant time trends were found between 1964 and 1978, although the age specific rates were not given.'4 As the death rate was not taken into account, however, a similar number of new cases in the period 1964-8 compared with 1974-8 may have been significant, as the further from the survey date so the number of cases ascertained should fall (it is more difficult to ascertain cases when recall of events and records become more sketchy), and the number of cases dying rises. A study recently carried out in northern Sweden found that the incidence of childhood epilepsy (0-15 years) was 89/100 000 in the period 1985-7,4 which compared with 134/100 000 when measured by a previous study in 1975." This represents only two incidence periods, and the differences could have been due to sampling error or different effectiveness of case ascertainment (no confidence limits were calculated).
The second important finding from our study is the high first attendance rates for elderly cases in the 10 years from 1984 to 1993. As discussed, the likelihood of elderly patients with epilepsy dying in the first five years is high, so that the first attendance rates in this age group are likely to be an underestimate of the true incidence, which may be up to 25% to 50% higher. This is the first study in which estimates of the incidence of epilepsy in elderly people has exceeded that of children. This has important health service planning implications, with epilepsy services at the primary care and specialist levels needing to be better targeted for this age group.
PROGNOSIS
Any analyses of the secular trends in the prognosis of epilepsy are hampered by methodological problems that render most studies not comparable-namely, different populations studied with different methodologies. The prognosis of epilepsy before the 1970s was held to be poor, with less the 20% entering remission," with more recent evidence showing that at the population level over 80% probably enter long term remission.5 This difference is unrelated to the changing fortunes of people with epilepsy, but due to patient selection bias. An improvement in the remission rates has, however, been suggested by Okuma and That histological grade provided no additional information on survival once a binary variable derived from our index was taken into account is a statement of fact. As Dr Hedley-Whyte is surprised by this fact, we suggest that she uses the index, given in the paper, on data which she has collected. It will be interesting to know whether the Daumas-Duport scheme contributes prognostic information which adds to data that can be obtained by non-invasive methods.
Hemibaflism in Parkinson's Disease
We read with interest the recent interchange between Obeso et al and Inzelberg and Korczyn in the J7ournal (1995;58:645-6).
Their discussion, and particularly the accompanying diagrams, outline current wisdom with respect to basal ganglia interactions and how changes in the activity of specific structures account for certain clinical manifestations. One critical clinical observation which is not readily explained by the current physiological models of the basal ganglia is the striking amelioration of levodopa-induced dyskinesiae with ventral posterior medial pallidotomy. The benefit obtained from this procedure with respect to primary parkinsonian signs is generally explained on the basis of a reduction in the overactivity of the GABAergic inhibitory input from the pars interna (GPi) to the thalamus ( fig 2B, p 646) . However, given the extent of the expected pallidal lesioning with this procedure, a pronounced reduction would have been expected in all pallidal outflow resulting in a similar picture to that depicted in fig 2F ( similar to an extensive lesion in the subthalamic nucleus (STN) causing dyskinesia). Instead, in our experience, mild, shortlived (< one hour) contralateral (and occasional ipsilateral) dyskinesiae occur at the time of lesioning in most patients followed by almost complete elimination of all forms of levodopa-induced dyskinesiae (peak dose dyskinesiae, diphasic dyskinesiae, and off period dystonia) in the contralateral limbs with additional improvements often seen in ipsilateral limbs as well. If the lesion is misplaced or partial (possibly comparable with the effects proposed in fig  2E with a partial STN lesion) , the ameliorative effects of the pallidotomy on levodopa induced dyskinesiae may be only shortlived.
There are other important neuroanatomical problems with the simplified schematic diagrams currently used to explain these clinical states. Figure 2 outlines the "indirect pathway" exclusively. However, as Parent and Hazrati' 2 have recently pointed out, there are major anatomical flaws in this simplification. These authors argue that the projection from the external segment of the globus pallidus (GPe) to the STN does not directly synapse with neurons projecting on to the GPi and substantias nigra (SN) pars reticulata. Instead, they connect with neurons which project back to the GPe forming a closed loop. The GPe then has a direct connection to the GPi which is all but ignored in current anatomical formulations. Another important criticism of current models emphasised by Parent and Hazrati'2 is the fact that the STN input to the GPi projects predominantly to neurons involved in associative rather than sensorimotor striatal inputs.
It is clear that there is a great deal more to be learned about the interactions of corticobasal ganglia-thalamocortical interactions in health and disease states. Although current models have successfully predicted some clinical findings, they fall well short of satisfactorily explaining many others. Careful electrophysiological, biochemical, and imaging assessments of non-human primates and patients undergoing surgical treatments for Parkinson's disease will hopefully assist in clarifying some of these confounding issues. 
